FDA Inspection
RePharm LLCRePharm LLC – FDA Inspection, Nov 15, 2023
Record Details
This FDA Inspection record concerns RePharm LLC, with an inspection on November 15, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d956da1e-9a08-4d15-acab-0d5131399560
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1224274
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of RePharm LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 25, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 3, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for RePharm LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.